Dan's Biz Bookshelf: 'Move Your Bus'
Driving Innovation: Direct Imaging vs. Conventional Exposure
It’s Only Common Sense: Selling to Today's Generation of Buyers
Analog Devices Appoints Dr. Laurie H. Glimcher to Board of Directors
August 19, 2020 | Business WireEstimated reading time: 2 minutes
Analog Devices, Inc. announced the appointment of Dr. Laurie H. Glimcher, MD, to the Board of Directors as an independent director, effective immediately. Dr. Glimcher is currently a Professor of Medicine at Harvard Medical School and the President and Chief Executive Officer of the Dana-Farber Cancer Institute.
Dr. Glimcher’s appointment expands the Board to 11 directors, nine of whom are independent. She will be a member of the Board’s Compensation Committee.
“We are excited to have Laurie join the ADI Board as we continue to invest and develop innovative healthcare solutions for our customers,” said Ray Stata, ADI Chairman of the Board. “Laurie is a distinguished immunologist with extensive experience working in both private and public settings to advance research, medical education and health policy. In addition, Laurie is a pioneering mentor and strong advocate promoting women’s role in science. The insights she has gained over her medical career will be of great benefit to ADI as we aim to accelerate the growth of our healthcare business.”
Dr. Glimcher speaks nationally and internationally on cancer, immunology, skeletal biology, and translational medicine, and has contributed more than 350 scholarly articles and papers to the medical literature. She also currently serves on the Board of Directors at GlaxoSmithKline Pharmaceutical Corporation.
In addition to a number of senior leadership roles held at both Harvard Medical School and Harvard School of Public Health from 1982 to present, she has also served as the Stephen and Suzanne Weiss Dean and Professor of Medicine of Weill Cornell Medicine and Provost for Medical Affairs of Cornell University. She is a member of the Board of Trustees at the Dana-Farber Cancer Institute and a member of the US National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences and the American Philosophical Society. She previously served on the Board of Directors of Bristol-Myers Squibb Pharmaceutical Corporation and Waters Corporation.
She is also the recipient of many awards and honors. In 2018, she received the American Association of Immunologists Lifetime Achievement Award; the Indiana University School of Medicine's Steven C. Beering Award for outstanding research contributions to advancement of biomedical or clinical science; and the L'Oréal-UNESCO Award for Women in Science. She has also received the 2017 George M. Kober Medal and the 2017 Award for Distinguished Research in the Biomedical Sciences from the Association of American Medical Colleges (AAMC).
Dr. Glimcher is a magna cum laude graduate of Radcliffe College, and holds an MD degree cum laude from Harvard Medical School.
Share on:
Suggested Items
TT Electronics Achieves ISO 13485 Medical Certification at Mexicali EMS Facility
06/27/2025 | TT ElectronicsThis milestone underscores TT Electronics’ commitment to delivering high-quality, compliant, and reliable manufacturing solutions to its global customers in healthcare and life sciences.
Benchmark Strengthens Presence in Jalisco with Grand Opening of Advanced Manufacturing Facility in Guadalajara
06/21/2025 | BUSINESS WIREBenchmark Electronics, Inc., a global provider of engineering, design, and manufacturing services, celebrated the grand opening of its brand-new manufacturing facility in Guadalajara, Mexico.
Quasar Medical to Acquire Nordson MEDICAL Design and Development business in Galway, Ireland and Tecate, Mexico
06/02/2025 | Quasar MedicalQuasar Medical, a global leader in the manufacturing of interventional and complex minimally invasive devices, announced it has signed a definitive agreement with Nordson Corporation to acquire its design and development contract manufacturing businesses in Galway, Ireland, and Tecate, Mexico.
Kimball Electronics to Open New Medical Manufacturing Facility
05/30/2025 | Kimball ElectronicsKimball Electronics has announced the addition of a 300,000 sq ft manufacturing facility in Indianapolis centered on the medical industry.
Evolve Manufacturing Celebrates 100 Years of Combined Leadership in Medical Device Manufacturing
05/26/2025 | Evolve ManufacturingEvolve Manufacturing Inc., a leading provider of end-to-end contract manufacturing services for medical device and life sciences instrument companies, proudly celebrates 100 years of combined medical device leadership among its expert team.